Progress Towards Development Of Multifunctional, Dopamine D2/d3 Receptor Agonists As Symptomatic And Disease-Modifying Therapeutic Agents For Parkinson' s Disease PROGRESS TOWARDS DEVELOPMENT OF MULTIFUNCTIONAL, DOPAMINE D2/D3 RECEPTOR AGONISTS AS SYMPTOMATIC AND DISEASE-MODIFYING THERAPEUTIC AGENTS FOR PARKINSON'S DISEASE

Mark Johnson, Mark Dissertation
2013 unpublished
fatcat:ntqyrc4smzgsdmqd5uanyq5toi